FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996253172> ?p ?o ?g. }

• W1996253172 endingPage "389" @default.
• W1996253172 startingPage "383" @default.
• W1996253172 abstract "We aimed at investigating by immunohistochemistry the relationship between cyclooxygenase-2 (COX-2) and estrogen (ER), and progesterone (PR) receptors in a single institution series of 90 primary untreated endometrial cancer patients. The simultaneous assessment of p53 protein, ki67, and neu protein has been carried out.Immunohistochemistry was performed on paraffin-embedded sections by using rabbit polyclonal antiserum against human COX-2, anti-ER (clone 1D5), and anti-PR (clone 1A6) monoclonal antibodies, anti ki67 (clone MIB-1) and p53 (clone DO-7), and polyclonal antibody anti human c-erbB2/neu.There was no difference in the distribution of COX-2, p53, and neu positive cases according to ER or PR positivity, while the percentage of ki67 positive endometrial tumors was significantly higher in ER negative versus ER positive tumors (54.5% versus 31.6%, P value = 0.044). ER and PR positive tumors showed a statistically significant association with clinicopathological parameters of better clinical outcome. There was no clear association between COX-2 positivity and any of the clinicopathological features. The percentage of ki67, p53, and neu positive tumors was found to be strictly related to more aggressive features. Only advanced stage of disease was found to be a predictor of poor prognosis (P value = 0.034). None of the biological parameters examined was shown to be associated with patient outcome.We showed that COX-2 expression is not correlated with ER, PR, p53, and neu, thus suggesting that COX-2-mediated activities may follow independent pathways. Our findings provide the rationale to design trials based on the combination of antihormones with inhibitors of COX-2 and neu in recurrent/metastatic endometrial cancer." @default.
• W1996253172 created "2016-06-24" @default.
• W1996253172 creator A5026048739 @default.
• W1996253172 creator A5030229940 @default.
• W1996253172 creator A5037735176 @default.
• W1996253172 creator A5053095305 @default.
• W1996253172 creator A5060930954 @default.
• W1996253172 creator A5089885243 @default.
• W1996253172 creator A5090583290 @default.
• W1996253172 date "2005-09-01" @default.
• W1996253172 modified "2023-10-13" @default.
• W1996253172 title "Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer" @default.
• W1996253172 cites W1769928764 @default.
• W1996253172 cites W1965647807 @default.
• W1996253172 cites W1977685162 @default.
• W1996253172 cites W1988827583 @default.
• W1996253172 cites W2029090558 @default.
• W1996253172 cites W2033887922 @default.
• W1996253172 cites W2039274017 @default.
• W1996253172 cites W2053468912 @default.
• W1996253172 cites W2057187298 @default.
• W1996253172 cites W2058526541 @default.
• W1996253172 cites W2058777317 @default.
• W1996253172 cites W2060163297 @default.
• W1996253172 cites W2062813587 @default.
• W1996253172 cites W2067222685 @default.
• W1996253172 cites W2072648072 @default.
• W1996253172 cites W2074063177 @default.
• W1996253172 cites W2076723390 @default.
• W1996253172 cites W2082753583 @default.
• W1996253172 cites W2082996759 @default.
• W1996253172 cites W2085316933 @default.
• W1996253172 cites W2089514388 @default.
• W1996253172 cites W2093113003 @default.
• W1996253172 cites W2094242183 @default.
• W1996253172 cites W2108717393 @default.
• W1996253172 cites W2109322259 @default.
• W1996253172 cites W2111439621 @default.
• W1996253172 cites W2128328278 @default.
• W1996253172 cites W2155206661 @default.
• W1996253172 cites W2161120923 @default.
• W1996253172 cites W3041047318 @default.
• W1996253172 cites W4239705377 @default.
• W1996253172 doi "https://doi.org/10.1016/j.ygyno.2005.04.024" @default.
• W1996253172 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15979129" @default.
• W1996253172 hasPublicationYear "2005" @default.
• W1996253172 type Work @default.
• W1996253172 sameAs 1996253172 @default.
• W1996253172 citedByCount "53" @default.
• W1996253172 countsByYear W19962531722012 @default.
• W1996253172 countsByYear W19962531722013 @default.
• W1996253172 countsByYear W19962531722014 @default.
• W1996253172 countsByYear W19962531722015 @default.
• W1996253172 countsByYear W19962531722016 @default.
• W1996253172 countsByYear W19962531722017 @default.
• W1996253172 countsByYear W19962531722018 @default.
• W1996253172 countsByYear W19962531722019 @default.
• W1996253172 countsByYear W19962531722020 @default.
• W1996253172 countsByYear W19962531722021 @default.
• W1996253172 countsByYear W19962531722022 @default.
• W1996253172 countsByYear W19962531722023 @default.
• W1996253172 crossrefType "journal-article" @default.
• W1996253172 hasAuthorship W1996253172A5026048739 @default.
• W1996253172 hasAuthorship W1996253172A5030229940 @default.
• W1996253172 hasAuthorship W1996253172A5037735176 @default.
• W1996253172 hasAuthorship W1996253172A5053095305 @default.
• W1996253172 hasAuthorship W1996253172A5060930954 @default.
• W1996253172 hasAuthorship W1996253172A5089885243 @default.
• W1996253172 hasAuthorship W1996253172A5090583290 @default.
• W1996253172 hasConcept C104317684 @default.
• W1996253172 hasConcept C121608353 @default.
• W1996253172 hasConcept C126322002 @default.
• W1996253172 hasConcept C159654299 @default.
• W1996253172 hasConcept C163864487 @default.
• W1996253172 hasConcept C170493617 @default.
• W1996253172 hasConcept C172313692 @default.
• W1996253172 hasConcept C181199279 @default.
• W1996253172 hasConcept C203014093 @default.
• W1996253172 hasConcept C204232928 @default.
• W1996253172 hasConcept C2777088508 @default.
• W1996253172 hasConcept C2777164284 @default.
• W1996253172 hasConcept C2779689624 @default.
• W1996253172 hasConcept C530470458 @default.
• W1996253172 hasConcept C542903549 @default.
• W1996253172 hasConcept C55493867 @default.
• W1996253172 hasConcept C71924100 @default.
• W1996253172 hasConcept C81089528 @default.
• W1996253172 hasConcept C84606932 @default.
• W1996253172 hasConcept C86803240 @default.
• W1996253172 hasConcept C91523082 @default.
• W1996253172 hasConcept C956191 @default.
• W1996253172 hasConcept C98717036 @default.
• W1996253172 hasConceptScore W1996253172C104317684 @default.
• W1996253172 hasConceptScore W1996253172C121608353 @default.
• W1996253172 hasConceptScore W1996253172C126322002 @default.
• W1996253172 hasConceptScore W1996253172C159654299 @default.
• W1996253172 hasConceptScore W1996253172C163864487 @default.
• W1996253172 hasConceptScore W1996253172C170493617 @default.

• next